000 03111nam a2200457 i 4500
999 _c362907
_d362907
_x1
001 362907
003 ES-MaUEC
005 20230221040153.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 210930s2021 sz | o |||| 0|eng d
020 _a9783030740283
024 7 _a10.1007/978-3-030-74028-3
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.L8
_b2021 EB
245 0 0 _aLung Cancer :
_bNew Understandings and Therapies
_cedited by Anne C. Chiang, Roy S. Herbst
250 _aFirst edition 2021
264 1 _aCham
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (VI, 264 páginas)
_b17 ilustraciones, 16 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aCurrent Cancer Research
_x2199-2592
505 0 _aTumor Microenvironment: Immune Effector and Suppressor Imbalance -- Biomarkers: is tumor mutational burden the new prognostic grail? -- Liquid biopsies: new technology and evidence -- Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance -- What can we learn from acquired resistance? -- Management of Brain Metastases -- Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors -- Therapeutic Advances in Small Cell Lung Cancer Management -- Small Cell Lung Cancer: Biology Advances -- Immunotherapy and Radiotherapy: New Strategies -- Ultimate Precision: Targeting Cancer but not Normal Self-Replication -- Index.
520 _aLung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.
988 _aSpringer_Medicine_2021
650 7 _2embne
_9168954
_aPulmones
_xCáncer
650 7 _2embne
_9182523
_aCáncer
_xInvestigación
700 1 _aChiang, Anne C.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHerbst, Roy S.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030740276
776 0 8 _iPrinted edition:
_z9783030740290
776 0 8 _iPrinted edition:
_z9783030740306
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-74028-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2022
_dz
_eb
_zSI